GST-π Antibodies: Empowering Protein Purification and Functional Research Innovation
23 Apr 2026
by AntBio
GST-π Antibodies: Empowering Protein Purification and Functional Research Innovation
Published by ANT BIO PTE. LTD.
Concept
Glutathione S-Transferase (GST) represents a widely conserved multifunctional enzyme superfamily across living organisms, with molecular weights ranging from 23 to 29 kDa and consisting of approximately 200–240 amino acids. Acting as key components of cellular detoxification systems, GSTs catalyze the conjugation of reduced glutathione with diverse electrophilic substrates, thereby neutralizing reactive molecules and facilitating metabolite excretion.
In humans, the GST family comprises several major isoforms, including alpha (α), pi (π), mu (μ), and theta (θ). Among these, GST‑π has emerged as a focal isoform in biomedical research due to its critical roles in tumor progression, drug resistance, and xenobiotic metabolism. Structurally, GST proteins typically function as homodimers, with each monomer containing two distinct domains: an N‑terminal domain forming the conserved glutathione‑binding site (G‑site), and a C‑terminal domain responsible for hydrophobic substrate recognition (H‑site). The unique structural features of the GST‑π active site distinguish it from other isoforms, laying the foundation for specific detection and functional analysis.
[Image Location: GST‑π Protein Structural Domain Diagram]
Research Frontier
Since the development of GST‑tag fusion protein technology by Smith and Johnson in 1988, this system has become a cornerstone of recombinant protein purification. The high‑affinity interaction between GST and immobilized glutathione enables efficient one‑step purification of fusion proteins under native conditions, greatly enhancing protein solubility and folding efficiency.
In parallel, GST‑π has attracted intense attention as a critical biomarker in oncology. Abnormally elevated GST‑π expression is closely associated with chemotherapy resistance in multiple tumor types, making it a vital indicator for cancer diagnosis, prognosis assessment, and therapeutic target discovery. Meanwhile, GST pull‑down assays, supported by highly specific GST‑π antibodies, have become powerful tools for mapping protein–protein interaction networks in proteome‑wide research.
[Image Location: GST‑tag Protein Purification Workflow Diagram]
Research Significance
GST‑π is not only indispensable for protein purification and interaction studies but also a pivotal player in physiological and pathological processes. Its high expression in tumor cells mediates resistance to a broad spectrum of chemotherapeutic agents, directly affecting clinical treatment outcomes. Additionally, as a major phase II detoxification enzyme, GST‑π participates in oxidative stress responses, chemical carcinogen metabolism, and organ toxicity evaluation, particularly in liver and kidney injury models.
Robust research tools, especially high‑quality GST‑π antibodies, are essential for deciphering these complex biological mechanisms. Reliable reagents support accurate detection, quantitative analysis, and in‑situ localization of GST‑π, bridging basic research and translational applications in cancer biology, drug development, and toxicology.
Related Mechanisms and Research Applications
Molecular Mechanisms
- GST‑π promotes detoxification by conjugating glutathione to cytotoxic electrophiles.
- Its overexpression reduces intracellular drug accumulation and enhances DNA repair, contributing to multidrug resistance.
- GST‑tag technology relies on GST‑glutathione binding for efficient affinity purification.
- GST pull‑down uses GST‑fused bait proteins to identify novel interacting partners.
Key Research Methods
-
GST‑tag Fusion Protein Purification
- Immobilized glutathione resin captures GST‑fusion proteins
- Mild elution with reduced glutathione preserves native protein structure
- Tag removal via site‑specific proteases (thrombin, Factor Xa)
-
GST Pull‑Down Assay
- Identify protein–protein interactions without target‑specific antibodies
- Compatible with mass spectrometry for unbiased interaction screening
-
Immunodetection (IHC, WB, IF)
- Localize and quantify GST‑π expression in cells and tissues
- Validate protein purification efficiency and tag cleavage
ANTBIO Product Empowerment
ANT BIO PTE. LTD. provides GST‑π Recombinant Rabbit Monoclonal Antibody, a next‑generation reagent optimized for protein research and disease studies.
Core Advantages
- Exceptional Specificity: Precisely recognizes human GST‑π with no cross‑reactivity with other GST isoforms; delivers clear cytoplasmic staining in FFPE tissues with minimal background.
- Superior Stability: Rigorous quality control ensures lot‑to‑lot consistency and reliable performance across IHC, Western Blot, and immunofluorescence.
- High Sensitivity: Detects low‑abundance endogenous GST‑π in drug‑resistant tumor models and toxicity samples.
Main Applications
- Tumor chemotherapy resistance profiling and prognosis evaluation
- Oxidative stress and cellular detoxification mechanism research
- Chemical carcinogen metabolism and safety pharmacology studies
- Liver and kidney toxicity assessment and biomarker validation
- Quality control for GST‑tag protein purification and pull‑down assays
Brand Mission
ANT BIO PTE. LTD. is committed to advancing life science research by delivering high‑quality, reliable reagents for protein science, oncology, and drug discovery. Our integrated portfolio — including antibodies, recombinant proteins, ELISA kits, and general laboratory reagents — supports robust, reproducible experiments worldwide. We continuously innovate to provide researchers with optimized tools to accelerate mechanistic discovery, therapeutic development, and translational medicine.
